An in-depth look to Lipella Pharmaceuticals Inc. operating, investing, and financing activities

LIPO free cash flow for Q3 24 is -653.1 k USD. For 2023, LIPO free cash flow was -3.16 M USD and operating cash flow was -3.15 M USD.